pentobarbital has been researched along with sodium glutamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Sepúlveda, AE; Gómez, C; Luján, M; Rodríguez, R; Servín, D | 1 |
| Ase, K; Chihara, K; Doi, N; Futamata, M; Hirotani, C; Ikegami, R; Kiyofuji, T; Kurasaki, S; Nakagawa, T; Okuno, T; Shimada, O; Ukai, K | 1 |
2 other study(ies) available for pentobarbital and sodium glutamate
| Article | Year |
|---|---|
Neonatal monosodium glutamate reduced pentobarbital hypnotic susceptibility in adult mice.
Topics: Animals; Animals, Newborn; Body Weight; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Male; Mice; Mice, Inbred Strains; Pentobarbital; Sodium Glutamate | 1991 |
Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Topics: Adrenocorticotropic Hormone; Anesthesia; Animals; Area Under Curve; Cells, Cultured; Corticosterone; Dogs; Growth Hormone; Growth Hormone-Releasing Hormone; Hormones; Hypnotics and Sedatives; Hypophysectomy; Hypothalamus; Male; Median Eminence; Oligopeptides; Pentobarbital; Pituitary Gland; Prolactin; Rats; Rats, Sprague-Dawley; Sodium Glutamate | 2004 |